top of page
Browse by category
Search
REBORN study: How to prioritise patients for BMS leading to the appropriate selection
Improvements in the physical component of quality of life (QoL) after metabolic and bariatric surgery (MBS) varies for patients with...
Expansion of bariatric surgery in the UK ‘challenging’ due to significant upfront economic investment
Expanding the capacity of bariatric and metabolic surgery (BMS) capacity in England beyond a small proportion of the eligible population...
Pneumonia and respiratory causes the largest causes of long-term mortality after BMS
Pneumonia and respiratory causes were found to be the largest causes of long-term mortality after bariatric and metabolic surgery (BMS),...
Blocking circulating protein interferon-γ pathway could lead to potential treatment for metabolic liver disease
University of Massachusetts Medical School researchers have identified a novel pathway in the progression of metabolic liver disease that...
Semaglutide reduces COVID-19 related deaths in patients with obesity and CVD
Semaglutide reduced the rates of COVID-19-related adverse events, including death, in those who had overweight or obesity and established...
European Society of Cardiology Obesity Consensus Statement
The European Society of Cardiology (ESC) Clinical Consensus Statement on Obesity and Cardiovascular Disease, presented at this year's ESC...
Browse by tag
bottom of page